
Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
MRNA | NASDAQ | USD | Real-time | |
MRNA | Mexico | MXN | Delayed | |
MRNA | Milan | EUR | Real-time | |
0QF | TradeGate | EUR | Delayed | |
0QF | Frankfurt | EUR | Delayed | |
MRNA_KZ | KASE | USD | Delayed | |
MRNA | Lima | USD | Delayed |
Moderna, Inc. is a biotechnology company that is focused on creating a transformative medicines based on messenger ribonucleic acid (mRNA), to improve the lives of patients. The Company’s mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane, or secreted proteins that have a therapeutic or preventive benefit with the potential to address a range of spectrum of diseases. It is developing vaccines and therapeutics for infectious diseases, immuno-oncology, rare diseases, autoimmune and cardiovascular diseases, independently and with its strategic collaborators. The Company develops technologies that enable the development of mRNA medicines for diverse applications. It has created modalities, including prophylactic vaccines, systemic secreted and cell surface therapeutics, cancer vaccines, intratumoral immuno-oncology, and systemic intracellular therapeutics. The Company develops technologies that enable the development of mRNA medicines.
Name | Age | Since | Title |
---|---|---|---|
Stephen A. Berenson | 61 | 2017 | Independent Non Executive Director |
Robert S. Langer | 73 | 2010 | Independent Non Executive Director & Member of Scientific Advisory Board |
Jack W. Szostak | - | 2014 | Chairman of Scientific Advisory Board |
Ron Eydelloth | - | - | Member of Scientific Advisory Board |
Paula T. Hammond | 58 | - | Member of Scientific Advisory Board |
Elizabeth Edith Tallett | 72 | 2020 | Independent Director |
Scott A. Canute | 61 | 2014 | Member of Technology Advisory Board |
Paul L. Sagan | 63 | 2018 | Independent Non Executive Director |
Ulrich H. von Andrian-Werburg | - | - | Member of Scientific Advisory Board |
Fred E. Regnier | - | 2014 | Member of Technology Advisory Board |
Michael Diamond | - | - | Member of Scientific Advisory Board |
Richard C. Willson | - | 2014 | Member of Technology Advisory Board |
Ralph Weissleder | - | - | Member of Scientific Advisory Board |
John G. Aunins | 61 | 2014 | Member of Technology Advisory Board |
James R. Swartz | - | 2014 | Member of Technology Advisory Board |
Francois Nader | 65 | 2019 | Independent Non Executive Director |
Sandra J. Horning | 73 | 2020 | Independent Director |
Elizabeth G. Nabel | 70 | 2021 | Independent Director |
Rachel Green | - | - | Member of Scientific Advisory Board |
Noubar B. Afeyan | 60 | 2010 | Co-Founder, Independent Non Executive Chairman & Member of Technology Advisory Board |
Stephane Bancel | 50 | 2011 | CEO & Director |
Melissa J. Moore | - | 2016 | Chief Scientific Officer & Member of Scientific Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review